2007 JASN IMPACT FACTOR 7.111	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by MONIER-FAUGERE, M.-C. Articles by MALLUCHE, H. H. Search for Related Content PubMed PubMed Citation Articles by MONIER-FAUGERE, M.-C. Articles by MALLUCHE, H. H.

High Prevalence of Low Bone Turnover and Occurrence of Osteomalacia after Kidney Transplantation

Division of Nephrology, Bone and Mineral Metabolism, Department of Internal Medicine, University of Kentucky, Lexington, Kentucky.

Correspondence to Dr. Hartmut H. Malluche, Division of Nephrology, Bone and Mineral Metabolism, Room MN 564, U.K. Medical Center, 800 Rose Street, Lexington, KY 40536-0298. Phone: 606-323-5049; Fax: 606-257-1052; E-mail: hhmall{at}pop.uky.edu

Abstract. Kidney transplantation corrects most of the metabolic abnormalities that cause renal osteodystrophy. However, many transplanted patients develop osteoporosis and other bone lesions that are related, at least in part, to their immunosuppressive regimen. The precise histologic patterns of bone disease after transplantation are not well defined. In a study designed to investigate this issue, 57 adult posttransplant patients agreed to undergo bone biopsies and blood drawings. There were 32 men and 25 women, mean age 45 ± 2 yr, who had received a kidney transplantation 5.6 ± 0.8 yr before biopsy. History of bone pain, fractures, and avascular necrosis was found in 22, 12, and 7 patients, respectively. Serum creatinine was 1.68 ± 0.1 mg/dl, 21% of patients were hypercalcemic, 63.2% had elevated parathyroid hormone (PTH) (>65 pg/ml), and 91.2% had normal calcitriol levels. Cancellous bone volume/tissue volume was below normal compared to age- and gender-matched control subjects in 56.1% of patients. Bone turnover (activation frequency) was low in 45.6%, normal in 28.1%, and elevated in 26.3% of patients. Bone formation rate/bone surface was low in 59.7%, normal in 35%, and elevated in 5.3% of the patients. Erosion surface/bone surface was high in 21.1% of patients. Mineralization was prolonged in 87.5% of patients, including 9 patients with osteomalacia and 12 patients with focal osteomalacia. Cumulative and maintenance doses of prednisone and time elapsed since transplantation correlated negatively with bone volume and bone turnover (r = -0.32 to -0.59, P < 0.05 to 0.01), whereas cumulative doses of cyclosporine or azathioprine, age, gender, or serum PTH levels did not. Regression analysis identified prednisone as the main factor responsible for low bone volume and bone turnover (r = 0.54 and r = 0.43, P < 0.01). No factors were found to predict delayed mineralization. The present study shows that low bone volume, low bone turnover, and generalized or focal osteomalacia are frequent histologic features in transplanted patients. The effects of age, gender, PTH, and cyclosporine on bone volume and bone turnover are apparently overridden by the prominent effects of glucocorticoids. The prevalence of mineralization defect in the presence of normal serum levels of calcidiol and calcitriol suggests vitamin D resistance and deserves further study.

This article has been cited by other articles:

				V Belostotsky, M Z Mughal, J L Berry, and N J A Webb Vitamin D deficiency in children with renal disease Arch. Dis. Child., November 1, 2008; 93(11): 959 - 962. [Abstract] [Full Text] [PDF]

				U. Kunzendorf, B. K. Kramer, W. Arns, J. Braun, J. Grossmann, F. Pietruck, H. Schmidt-Gayk, A. Schwarz, E. Ziegler, H. Sperschneider, et al. Bone disease after renal transplantation Nephrol. Dial. Transplant., February 1, 2008; 23(2): 450 - 458. [Full Text] [PDF]

				A. Schwarz, G. Rustien, S. Merkel, J. Radermacher, and H. Haller Decreased renal transplant function after parathyroidectomy Nephrol. Dial. Transplant., February 1, 2007; 22(2): 584 - 591. [Abstract] [Full Text] [PDF]

				J. R. Weisinger, R. G. Carlini, E. Rojas, and E. Bellorin-Font Bone Disease after Renal Transplantation Clin. J. Am. Soc. Nephrol., November 1, 2006; 1(6): 1300 - 1313. [Abstract] [Full Text] [PDF]

				M. Freundlich, E. Alonzo, E. Bellorin-Font, and J. R. Weisinger Increased Osteoblastic Activity and Expression of Receptor Activator of NF-{kappa}B Ligand in Nonuremic Nephrotic Syndrome J. Am. Soc. Nephrol., July 1, 2005; 16(7): 2198 - 2204. [Abstract] [Full Text] [PDF]

				N. M. Maalouf and E. Shane Osteoporosis after Solid Organ Transplantation J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2456 - 2465. [Abstract] [Full Text] [PDF]

				M. Coco, D. Glicklich, M. C. Faugere, L. Burris, I. Bognar, P. Durkin, V. Tellis, S. Greenstein, R. Schechner, K. Figueroa, et al. Prevention of Bone Loss in Renal Transplant Recipients: A Prospective, Randomized Trial of Intravenous Pamidronate J. Am. Soc. Nephrol., October 1, 2003; 14(10): 2669 - 2676. [Abstract] [Full Text] [PDF]

				H. Sperschneider and G. Stein Bone disease after renal transplantation Nephrol. Dial. Transplant., May 1, 2003; 18(5): 874 - 877. [Full Text] [PDF]

				A. Torres, V. Lorenzo, and E. Salido Calcium Metabolism and Skeletal Problems after Transplantation J. Am. Soc. Nephrol., February 1, 2002; 13(2): 551 - 558. [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673